Courtney Boswell
Family · Westfield, INNPI 1730650581
Payments from drug & device makers
Across 147 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$514
- Neurocrine Biosciences, Inc.$306
- Teva Pharmaceuticals USA, Inc.$273
- Johnson & Johnson$200
- Alkermes, Inc.$157
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$150
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,663100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $514 |
| Neurocrine Biosciences, Inc. | 14 | $306 |
| Teva Pharmaceuticals USA, Inc. | 20 | $273 |
| Johnson & Johnson | 13 | $200 |
| Alkermes, Inc. | 8 | $157 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $150 |
| Bioxcel Therapeutics, Inc. | 1 | $142 |
| Gilead | 3 | $140 |
| Indivior Inc. | 7 | $133 |
| Vanda Pharmaceuticals Inc. | 5 | $127 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Lundbeck LLC | 4 | $71 |
| Corium, LLC | 4 | $71 |
| E.r. Squibb & Sons, L.L.C. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Noven Therapeutics, LLC | 3 | $46 |
| Ironshore Pharmaceuticals Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $21 |
| Viiv Healthcare Company | 1 | $18 |
| Biogen | 1 | $18 |
| Tris Pharma Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,663 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 15 | $422 |
| Dicyclomine Hcl | 17 | $317 |
| Potassium Chloride | 18 | $297 |
| Mirtazapine | 11 | $273 |
| Atorvastatin Calcium | 41 | $239 |
| Metformin Hcl | 18 | $158 |
| Omeprazole | 13 | $130 |
| Losartan Potassium | 15 | $119 |
| Glimepiride | 12 | $112 |
| Hydrochlorothiazide | 27 | $95 |
| Clonidine Hcl | 13 | $94 |
| Lisinopril | 16 | $72 |
| Meloxicam | 19 | $72 |
| Amlodipine Besylate | 26 | $72 |
| Atenolol | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other family in Westfield
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.